Antidepressants interact with an LPA3 receptor binding site: functional and docking studies
Karina Helivier Solís, Ana I. Jardon-Ibanez, María Teresa Romero‐Ávila, Ruth Rincón-Heredia, Sergio Romero-Romero, José Correa‐Basurto, Jesús Adolfo García-Sáinz
This study investigates how antidepressants interact with LPA3 receptors through functional assays and docking simulations, revealing distinct effects on calcium and ERK 1/2 signaling.
European Journal of Pharmacology · Mar 26, 2026Peer-reviewedPharmacology & Toxicology